IMproved PRegnancy Outcome by Early Detection (IMPROvED)
Personalized Medicine for Pregnant Women: Novel Metabolomic and Proteomic Biomarkers to Detect Pre-eclampsia and Improve Outcome.
Sponsor: Accelopment AG
A observational or N/A phase clinical study on Pre-eclampsia and Pregnancy, this trial is ongoing. The trial is conducted by Accelopment AG and has accumulated 14 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
14 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Dec 2021 — Jul 2024 [monthly]
Unknown Status
-
Jan 2021 — Dec 2021 [monthly]
Unknown Status
-
Nov 2020 — Jan 2021 [monthly]
Unknown Status
▶ Show 9 earlier versions
-
Feb 2019 — Nov 2020 [monthly]
Unknown Status
-
Dec 2018 — Feb 2019 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jun 2018 — Dec 2018 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Feb 2018 — Apr 2018 [monthly]
Recruiting NA
-
Aug 2017 — Feb 2018 [monthly]
Recruiting NA
-
Feb 2017 — Aug 2017 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Nov 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Accelopment AG
- Copenhagen Trial Unit, Center for Clinical Intervention Research
- Erasmus Medical Center
- INFANT centre, University College Cork, Republic of Ireland
- Karolinska University
- Keele University
- Louise Kenny
- MedSciNet AB, Stockholm, Sweden
- Metabolomic Diagnostics Ltd, Cork, Ireland
- MyCartis, Ghent, Belgium
- University of Groningen, The Netherlands
- University of Liverpool
For direct contact, visit the study record on ClinicalTrials.gov .